SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-055770
Filing Date
2023-05-04
Accepted
2023-05-04 07:12:23
Documents
14
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314422d1_8k.htm   iXBRL 8-K 27582
2 EXHIBIT 99.1 tm2314422d1_ex99-1.htm EX-99.1 171195
6 GRAPHIC tm2314422d1_ex99-1img001.jpg GRAPHIC 24692
  Complete submission text file 0001104659-23-055770.txt   430128

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20230504.xsd EX-101.SCH 3051
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20230504_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20230504_pre.xml EX-101.PRE 22607
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2314422d1_8k_htm.xml XML 3608
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 23886436
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences